Pay in 4 interest-free payments of $6.24 Learn more
Ships within 48 hours · Estimated delivery Aug 20 - Aug 25
Table of Contents Understanding Medicare coverage for GLP-1 therapies How expanded reimbursement changes audience targeting Why pharma media strategies are evolving Future opportunities for healthcare marketers Conclusion Frequently Asked Questions Why Medicare Coverage for GLP-1 Therapies Matters to Healthcare Marketers GLP-1 receptor agonists, including Ozempic, Wegovy, Mounjaro, and Zepbound, have transformed treatment for type 2 diabetes and obesity
A new study published in Frontiers in Nutrition highlights the utility of this diet in managing symptoms of irritable bowel syndrome
Your doctor will review your current medications, overall health and treatment goals to determine whether GLP-1 therapy is appropriate
Do you have a question about diabetes and weight loss drugs
US$ 25.79
US$ 26.17
US$ 27.22
US$ 28.80
US$ 23.63
